Your browser doesn't support javascript.
loading
SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling.
Zhou, Zhongqiu; Zhang, Zhuojun; Chen, Han; Bao, Wenhao; Kuang, Xiangqin; Zhou, Ping; Gao, Zhiqing; Li, Difeng; Xie, Xiaoyi; Yang, Chunxiao; Chen, Xuhong; Pan, Jinyuan; Tang, Ruiming; Feng, Zhengfu; Zhou, Lihuan; Wang, Lan; Yang, Jianan; Jiang, Lili.
Afiliação
  • Zhou Z; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
  • Zhang Z; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, 511436, Guangzhou, China.
  • Chen H; Meishan Women and Children's Hospital, Alliance Hospital of West China Second University Hospital, Sichuan University, 620000, Meishan, China.
  • Bao W; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
  • Kuang X; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, 511436, Guangzhou, China.
  • Zhou P; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
  • Gao Z; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, 511436, Guangzhou, China.
  • Li D; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
  • Xie X; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, 511436, Guangzhou, China.
  • Yang C; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
  • Chen X; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, 511436, Guangzhou, China.
  • Pan J; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
  • Tang R; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, 511436, Guangzhou, China.
  • Feng Z; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
  • Zhou L; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, 511436, Guangzhou, China.
  • Wang L; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
  • Yang J; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, 511436, Guangzhou, China.
  • Jiang L; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, 510095, Guangzhou, China.
Br J Cancer ; 127(2): 211-222, 2022 07.
Article em En | MEDLINE | ID: mdl-35484216
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Antígenos de Diferenciação Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Antígenos de Diferenciação Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article